Nadolol
"Nadolol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A non-selective beta-adrenergic antagonist with a long half-life, used in cardiovascular disease to treat arrhythmias, angina pectoris, and hypertension. Nadolol is also used for MIGRAINE DISORDERS and for tremor.
| Descriptor ID |
D009248
|
| MeSH Number(s) |
D02.033.100.624.698.601 D02.033.755.624.698.601 D02.092.063.624.698.601
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nadolol".
Below are MeSH descriptors whose meaning is more specific than "Nadolol".
This graph shows the total number of publications written about "Nadolol" by people in this website by year, and whether "Nadolol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nadolol" by people in Profiles.
-
Randhawa HK, Sibbald C, Garcia Romero MT, Pope E. Oral Nadolol for the Treatment of Infantile Hemangiomas: A Single-Institution Retrospective Cohort Study. Pediatr Dermatol. 2015 Sep-Oct; 32(5):690-5.
-
Pope E, Chakkittakandiyil A, Lara-Corrales I, Maki E, Weinstein M. Expanding the therapeutic repertoire of infantile haemangiomas: cohort-blinded study of oral nadolol compared with propranolol. Br J Dermatol. 2013 Jan; 168(1):222-4.
-
Gow RM, Snider K, Chiu-Man C. Atrial fibrillation in a LQTS patient with an ICD programmed for managed ventricular pacing: what is the cause? Pacing Clin Electrophysiol. 2012 Mar; 35(3):357-9.